HeimBONEX • STO
add
Bonesupport Holding AB
Við síðustu lokun
299,00 kr.
Dagbil
300,00 kr. - 316,20 kr.
Árabil
216,20 kr. - 405,80 kr.
Markaðsvirði
20,80 ma. SEK
Meðalmagn
163,16 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
STO
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (SEK) | des. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 257,01 m. | 48,78% |
Rekstrarkostnaður | 192,77 m. | 24,82% |
Nettótekjur | 53,91 m. | 402,26% |
Hagnaðarhlutfall | 20,98 | 237,84% |
Hagnaður á hvern hlut | — | — |
EBITDA | 45,80 m. | 889,44% |
Virkt skatthlutfall | 25,19% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (SEK) | des. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 227,00 m. | 35,65% |
Heildareignir | 879,69 m. | 27,71% |
Heildarskuldir | 152,23 m. | 5,98% |
Eigið fé alls | 727,46 m. | — |
Útistandandi hlutabréf | 65,86 m. | — |
Eiginfjárgengi | 27,06 | — |
Arðsemi eigna | 13,65% | — |
Ávöxtun eigin fjár | 15,95% | — |
Peningaflæði
Breyting á handbæru fé
| (SEK) | des. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 53,91 m. | 402,26% |
Handbært fé frá rekstri | 73,20 m. | 471,31% |
Reiðufé frá fjárfestingum | -1,71 m. | 57,61% |
Reiðufé frá fjármögnun | -620,00 þ. | 54,34% |
Breyting á handbæru fé | 73,85 m. | 2.137,76% |
Frjálst peningaflæði | 26,29 m. | -19,11% |
Um
BoneSupport AB is a Swedish biotech company active at the Ideon Science Park in the university town of Lund in Skåne, Sweden, founded in 1999 by Lars Lidgren, Professor of Orthopedic Surgery and Academic Head of Department at Lund University Hospital in Sweden which is a member of the ISOC group of orthopaedic centers. The company has been funded with more than SEK 500 million in venture capital from inter alia HealthCap, Lundbeck foundation and Industrifonden, making it one of the largest ventures in the Swedish medical technologies industry. Wikipedia
Framkvæmdastjóri
Stofnsett
1999
Vefsvæði
Starfsfólk
140
